Skip to content
SFN info

Impaired glucose intolerance and Small Fiber Neuropathy (SFN)

Impaired Glucose Intolerance

Description:

Impaired glucose tolerance (IGT) is a pre-diabetic state of hyperglycemia that is associated with insulin resistance and increased risk of cardiovascular pathology. IGT may precede type 2 diabetes mellitus by many years. It is characterized by higher than normal blood glucose levels, but not high enough to be classified as diabetes.

Prevalence:

According to the World Health Organization, it is estimated that around 7.3% of adults aged 18 years and older had impaired glucose tolerance in 2014. This prevalence is expected to rise due to increasing obesity rates and sedentary lifestyles.

Risk Factors:

  • Age: The risk of developing IGT increases with age.
  • Weight: Overweight and obesity are significant risk factors for IGT.
  • Family History: A family history of diabetes increases the risk of IGT.
  • Physical Inactivity: Lack of physical activity is a risk factor for IGT.
  • Poor Diet: A diet high in fats and sugars can contribute to the development of IGT.
  • History of Gestational Diabetes: Women who have had gestational diabetes or who have given birth to a baby weighing more than 9 pounds are at increased risk of developing IGT.

Prognosis:

IGT is often a precursor to type 2 diabetes. Without intervention, about 30-50% of people with IGT will develop type 2 diabetes within five years. However, lifestyle modifications such as diet and exercise can often prevent or delay the onset of diabetes. Complications associated with IGT are similar to those of diabetes, including heart disease and stroke.

Prevention:

Preventive measures for IGT are similar to those for type 2 diabetes and include:

  • Maintaining a Healthy Weight: This can be achieved through a balanced diet and regular exercise.
  • Regular Exercise: Physical activity can help control weight, uses up glucose as energy and makes cells more sensitive to insulin.
  • Healthy Eating: A diet rich in fruits, vegetables, whole grains, lean protein, and low-fat dairy can help prevent IGT.
  • Regular Check-ups: Regular health check-ups can help detect any early signs of IGT.

Epidemiology:

The prevalence of IGT varies by region, age, and gender. It is more common in older adults and in certain racial and ethnic groups, including African Americans, Hispanic Americans, American Indians, and Asian Americans. The prevalence is also higher in urban areas compared to rural areas due to lifestyle differences. In terms of gender, some studies suggest that IGT is slightly more common in women than in men. However, this can vary depending on the population studied.

Impaired glucose tolerance (IGT), connection to Small Fiber Neuropathy (SFN)

Association

Impaired glucose tolerance (IGT) is a pre-diabetic state of hyperglycemia that is associated with insulin resistance and increased risk of cardiovascular disease. It can progress to type 2 diabetes if not managed properly.

IGT is linked to Small Fiber Neuropathy (SFN) through several mechanisms:

  • Hyperglycemia: Chronic high blood sugar levels, as seen in IGT, can damage nerves over time. This is particularly true for small fibers, which are more susceptible to damage from elevated glucose levels.
  • Insulin resistance: Insulin resistance, a hallmark of IGT, can lead to metabolic changes in nerve cells, leading to their dysfunction and the development of SFN.
  • Inflammation: IGT is associated with increased levels of inflammatory markers, which can lead to nerve damage and SFN.
  • Vascular damage: IGT can cause damage to the small blood vessels that supply nerves, leading to nerve damage and SFN.

Research Updates

Recent research continues to support the link between IGT and SFN.

  • A 2020 study published in the “Journal of Diabetes and its Complications” found that individuals with IGT had a higher prevalence of SFN compared to those with normal glucose tolerance, and that SFN was associated with worse glucose tolerance.
  • A 2019 study published in the “Journal of Neurology, Neurosurgery, and Psychiatry” found that IGT was associated with a higher risk of developing SFN, and that this risk increased with the severity of the IGT.

These studies suggest that IGT is not only a risk factor for SFN, but that it may also contribute to the severity of the condition.

However, more research is needed to fully understand the mechanisms underlying the link between IGT and SFN, and to develop effective strategies for preventing and treating SFN in individuals with IGT.

Symptoms of Impaired Glucose Intolerance

List of Symptoms:

Impaired glucose intolerance (IGT), also known as prediabetes, is a condition where blood glucose levels are higher than normal but not high enough to be classified as diabetes. It is often asymptomatic, but some people may experience:

  • Increased thirst: This is due to the excess sugar present in the bloodstream, which pulls fluid from the tissues.
  • Frequent urination: As a result of increased thirst and fluid intake.
  • Fatigue: High blood sugar can cause tiredness and lack of energy.
  • Blurred vision: High levels of blood sugar can cause the lens in the eyes to swell, affecting your ability to see.
  • Slow healing of wounds: High blood sugar levels can affect the body’s ability to heal wounds.
  • Frequent infections: High blood sugar levels can affect the immune system, making you more prone to infections.

It’s important to note that small fiber neuropathy (SFN) is a possible complication of impaired glucose intolerance. SFN can cause symptoms such as pain, burning, tingling, or numbness in the extremities.

Severity:

The severity of symptoms can vary widely among individuals with impaired glucose intolerance. Some people may not experience any symptoms at all, while others may have noticeable symptoms. The severity of symptoms can also increase as the condition progresses and blood sugar levels continue to rise.

Onset:

Impaired glucose intolerance is often asymptomatic in the early stages, and symptoms may not appear until the condition has progressed. This is why regular screening for blood glucose levels is important, especially for those with risk factors for the condition. If symptoms do appear, they are typically the same as those of type 2 diabetes and may include increased thirst, frequent urination, fatigue, and blurred vision. Symptoms related to small fiber neuropathy, such as pain or numbness in the extremities, may also occur in later stages of the condition.

Diagnosis of Impaired Glucose Intolerance

Methods:

Impaired glucose tolerance (IGT) is typically diagnosed using the following methods:

  • Oral Glucose Tolerance Test (OGTT): This is the standard test for diagnosing IGT. The patient fasts overnight, then a blood sample is taken to measure baseline fasting blood glucose. The patient then drinks a solution containing 75 grams of glucose, and blood samples are taken at intervals for 2 hours to measure how the body is handling the glucose. IGT is diagnosed if the 2-hour blood glucose level is between 140 and 199 mg/dL.

  • Fasting Plasma Glucose Test (FPG): This test measures fasting blood glucose levels. While it is not typically used to diagnose IGT, a fasting blood glucose level between 100 and 125 mg/dL can indicate impaired fasting glucose (IFG), a condition related to IGT.

  • Hemoglobin A1C Test: This test measures average blood glucose levels over the past 2 to 3 months. While it is not typically used to diagnose IGT, an A1C level between 5.7% and 6.4% can indicate a higher risk of developing diabetes.

Differential Diagnosis:

Several conditions can present similar symptoms to IGT and may be considered in the differential diagnosis, especially in the context of small fiber neuropathy (SFN):

  • Diabetes Mellitus: Both type 1 and type 2 diabetes can cause symptoms similar to IGT, including increased thirst, frequent urination, and fatigue. Diabetes is diagnosed if the 2-hour blood glucose level during an OGTT is 200 mg/dL or higher, or if the fasting blood glucose level is 126 mg/dL or higher.

  • Metabolic Syndrome: This is a cluster of conditions that increase the risk of heart disease, stroke, and type 2 diabetes. It can cause similar symptoms to IGT and is diagnosed based on the presence of three or more of the following: abdominal obesity, high triglyceride levels, low HDL cholesterol levels, high blood pressure, and high fasting blood sugar.

  • Hypoglycemia: This condition, characterized by abnormally low blood glucose levels, can cause symptoms similar to IGT, including hunger, sweating, and shakiness. It is diagnosed based on a blood glucose level below 70 mg/dL.

Limitations:

There are several limitations and challenges in diagnosing IGT:

  • Overlap with Normal Glucose Tolerance and Diabetes: The blood glucose levels used to diagnose IGT overlap with the ranges for normal glucose tolerance and diabetes, which can make diagnosis challenging.

  • Variability in Blood Glucose Levels: Blood glucose levels can vary day to day and even hour to hour, which can affect the results of diagnostic tests.

  • Lack of Symptoms: Many people with IGT do not have any symptoms, which means the condition can go undiagnosed until it progresses to diabetes.

  • Influence of Other Conditions: Conditions like pregnancy, illness, and certain medications can affect blood glucose levels and potentially lead to a misdiagnosis of IGT.

Treatments for Impaired Glucose Intolerance

Options:

Impaired glucose intolerance (IGT) is a pre-diabetic state of hyperglycemia that is associated with insulin resistance and increased risk of cardiovascular pathology. When linked with Small Fiber Neuropathy (SFN), the treatment options are generally aimed at managing the blood glucose levels and improving the overall health of the patient. These include:

  • Lifestyle Modifications: This is the first line of treatment for IGT and includes a healthy diet, regular physical activity, and maintaining a healthy weight. These changes can help improve the body’s use of insulin and help keep blood glucose levels in the normal range.

  • Medications: If lifestyle changes are not enough, medications may be prescribed. Metformin is often used to help control blood sugar levels in people with IGT. Other medications like Acarbose and Pioglitazone can also be used.

  • Monitoring: Regular monitoring of blood glucose levels is essential in managing IGT. This helps to ensure that the treatment plan is working and can be adjusted as necessary.

Effectiveness:

The effectiveness of these treatments varies from person to person. Lifestyle modifications have been shown to reduce the progression of IGT to diabetes by up to 58%. Metformin can reduce this risk by up to 31%. However, the effectiveness of these treatments can be influenced by factors such as age, weight, and overall health.

Side Effects:

  • Lifestyle Modifications: There are generally no side effects associated with lifestyle modifications. However, sudden changes in diet and exercise should be done under the supervision of a healthcare provider to avoid any potential risks.

  • Medications: Side effects of Metformin can include stomach upset, diarrhea, and metallic taste in the mouth. Acarbose can cause bloating, diarrhea, and abdominal discomfort. Pioglitazone can cause weight gain, swelling, and an increased risk of heart failure.

Recent Advancements:

Recent advancements in the treatment of IGT have focused on the development of new medications and therapies to improve insulin sensitivity and reduce blood glucose levels. For example, research is being conducted on the use of GLP-1 receptor agonists, which are medications that mimic the action of a hormone in the body that helps to regulate blood sugar levels. However, these are still in the experimental stages and are not yet widely available for use in treating IGT.